Put companies on watchlist
CompuGroup Medical SE & Co. KGaA
ISIN: DE000A288904
WKN: A28890
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

CompuGroup Medical SE & Co. KGaA · ISIN: DE000A288904 · EQS - Company News (90 News)
Country: Germany · Primary market: Germany · EQS NID: 1614505
24 April 2023 08:27AM

CompuGroup Medical acquires majority stake in patient portal provider m.Doc


EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Investment
CompuGroup Medical acquires majority stake in patient portal provider m.Doc

24.04.2023 / 08:27 CET/CEST
The issuer is solely responsible for the content of this announcement.


Koblenz. CompuGroup Medical SE & Co. KGaA has acquired 51% of m.Doc GmbH. m.Doc develops patient portals and digital applications for hospitals, rehabilitation and care facilities. Founded in 2016, the company has offices in Cologne and Lisbon with around 110 employees. CompuGroup Medical will further develop m.Doc's patient portal and integrate it into its systems. CompuGroup Medical will also extend the CLICKDOC solution for appointment booking and video consultations and leverage synergies for messenger solutions. The transaction is an important milestone towards enabling the full digital patient journey in both inpatient and outpatient settings and optimizes referrals from general practitioners to hospitals. 

m.Doc focuses on digitizing everyday hospital life, integrating patients into administrative and medical processes before, during and after inpatient treatment, and providing far-reaching relief and support for medical staff. The technical basis for the m.Doc applications is the Smart Health Platform, which connects m.Doc's modular patient portal with services such as video consultations, appointment booking, medication plans, treatment documents and much more. The interoperability of the m.Doc platform with all common hospital information systems will be further promoted for the benefit of customers and partners. m.Doc's vision that everyone can reach their doctor anytime and anywhere via mobile devices fits perfectly with CompuGroup Medical's purpose: “Nobody should suffer or die because at some point medical information was missing.” 

“The acquisition of m.Doc is an excellent addition to our product portfolio. With m.Doc, we acquire a product suite with an attractive customer base of more than 300 hospitals, making us one of the leading providers in the digital integration of patients into the treatment process in the inpatient sector”, emphasizes Hannes Reichl, Managing Director Inpatient and Social Care at CompuGroup Medical SE & Co. KGaA. “Especially in the hospital sector, there is a high demand for new solutions of digital patient communication. This development is gaining additional momentum due to the German Hospital Future Act.” 

“With CompuGroup Medical, we are entering the next phase of our growth. The financial strength of the group, the large customer base and especially the experience in implementing complex projects are an enormous added value for us as a team and for our customers. In addition, we will work on deep integration with CompuGroup Medical's solutions to offer a fully integrated end-to-end patient journey”, says Admir Kulin, Managing Director of m.Doc GmbH, looking positively to the future.


About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.130 billion in 2022, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its webbased personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 20 countries and products in 60 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 9,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.
 


24.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1614505

 
End of News EQS News Service

1614505  24.04.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1614505&application_name=news&site_id=boersengefluester_html
Visual performance / price development - CompuGroup Medical SE & Co. KGaA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.